Insider trades
Adam Crystal, President of Tango Therapeutics TNGX, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $4.2M. The latest trade was on 06/01.
Adam Crystal
President, R&D
- Company
- Tango Therapeutics TNGX
- First filing
- 23/02/01
- Trades
- 37 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$4.2M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TNGX | Open-market sale10b5-1 plan | 06/01 | 06/03 | 27,000 sh2 trades | $22.88avg. | $617,646.6 | −18.9% |
TNGX | Open-market sale10b5-1 plan | 05/01 | 05/05 | 27,000 sh2 trades | $21.22avg. | $573,021 | −18.9% |
| Open-market sale10b5-1 plan | 04/15 | 04/16 | 38,460 sh | $25.00 | $961,500 | −25.5% | |
| Open-market sale10b5-1 plan | 04/01 | 04/02 | 27,000 sh | $21.20 | $572,400 | −19.3% | |
| Open-market sale10b5-1 plan | 03/25 | 03/27 | 12,000 sh | $20.11 | $241,320 | −9.6% | |
| Open-market sale10b5-1 plan | 03/05 | 03/09 | 20,251 sh | $15.00 | $303,765 | −15.2% | |
| Open-market sale10b5-1 plan | 02/25 | 02/27 | 54,345 sh | $12.77 | $693,985.65 | −29.0% | |
TNGX | Open-market sale | 02/03 | 02/04 | 18,452 sh2 trades | $12.27avg. | $226,350.16 | −9.0% |
TNGX | Open-market sale | 25/02/04–25/02/05 | 25/02/06 | 14,283 sh2 trades | $3.07avg. | $43,870.84 | −8.3% |
TNGX | Open-market sale | 24/02/06–24/02/07 | 24/02/08 | 8,371 sh2 trades | $12.59avg. | $105,384.74 | −6.5% |
| Open-market sale | 23/11/01 | 23/11/02 | 7,507 sh | $8.39 | $62,983.73 | −8.5% |